Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis

S. A. Greenberg, B. W. Higgs, C. Morehouse, R. J. Walsh, S. Won Kong, P. Brohawn, W. Zhu, A. Amato, M. Salajegheh, B. White, P. A. Kiener, B. Jallal, Y. Yao

Research output: Contribution to journalArticle

Abstract

The objective of this study was to evaluate the relationship between blood mRNA, disease activity and treatment effects in a longitudinal study of patients with dermatomyositis (DM) or polymyositis (PM). In all, 24 patients with DM or PM were followed for up to 6 years (mean of 1.9 years) at 2-7 follow-up visits while receiving standard clinical care. Clinical data and blood samples collected at 80 patient visits were used for the analysis of cytokine-induced gene expression for the signaling pathways of type 1 interferon (IFN), tumor necrosis factor-α, IL-1β, granulocyte-monocyte colony-stimulating factor, IL-10 and IL-13. A type 1 IFN signature score, but not other cytokine signature scores in the blood of patients with DM or PM, correlated highly with disease activity, decreased significantly with immunomodulatory therapies and showed concordant changes with major changes in disease activity. Type 1 IFN signature score in the blood correlates with disease activity in longitudinal follow-up of individual patients with DM or PM. The type 1 IFN-inducible gene transcripts in the blood have potential utility for monitoring disease activity in patients with DM or PM.

Original languageEnglish (US)
Pages (from-to)207-213
Number of pages7
JournalGenes and Immunity
Volume13
Issue number3
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Interferon Type I
Dermatomyositis
Cytokines
Gene Expression
Interleukin-13
Immunomodulation
Hematologic Diseases
Granulocyte Colony-Stimulating Factor
Interleukin-1
Interleukin-10
Longitudinal Studies
Monocytes
Tumor Necrosis Factor-alpha
Messenger RNA
Genes

Keywords

  • dermatomyositis
  • genomics
  • polymyositis
  • type 1 interferon

ASJC Scopus subject areas

  • Genetics(clinical)
  • Immunology
  • Genetics

Cite this

Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. / Greenberg, S. A.; Higgs, B. W.; Morehouse, C.; Walsh, R. J.; Won Kong, S.; Brohawn, P.; Zhu, W.; Amato, A.; Salajegheh, M.; White, B.; Kiener, P. A.; Jallal, B.; Yao, Y.

In: Genes and Immunity, Vol. 13, No. 3, 04.2012, p. 207-213.

Research output: Contribution to journalArticle

Greenberg, SA, Higgs, BW, Morehouse, C, Walsh, RJ, Won Kong, S, Brohawn, P, Zhu, W, Amato, A, Salajegheh, M, White, B, Kiener, PA, Jallal, B & Yao, Y 2012, 'Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis', Genes and Immunity, vol. 13, no. 3, pp. 207-213. https://doi.org/10.1038/gene.2011.61
Greenberg, S. A. ; Higgs, B. W. ; Morehouse, C. ; Walsh, R. J. ; Won Kong, S. ; Brohawn, P. ; Zhu, W. ; Amato, A. ; Salajegheh, M. ; White, B. ; Kiener, P. A. ; Jallal, B. ; Yao, Y. / Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. In: Genes and Immunity. 2012 ; Vol. 13, No. 3. pp. 207-213.
@article{92777329bef847ff96772833ac09b07b,
title = "Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis",
abstract = "The objective of this study was to evaluate the relationship between blood mRNA, disease activity and treatment effects in a longitudinal study of patients with dermatomyositis (DM) or polymyositis (PM). In all, 24 patients with DM or PM were followed for up to 6 years (mean of 1.9 years) at 2-7 follow-up visits while receiving standard clinical care. Clinical data and blood samples collected at 80 patient visits were used for the analysis of cytokine-induced gene expression for the signaling pathways of type 1 interferon (IFN), tumor necrosis factor-α, IL-1β, granulocyte-monocyte colony-stimulating factor, IL-10 and IL-13. A type 1 IFN signature score, but not other cytokine signature scores in the blood of patients with DM or PM, correlated highly with disease activity, decreased significantly with immunomodulatory therapies and showed concordant changes with major changes in disease activity. Type 1 IFN signature score in the blood correlates with disease activity in longitudinal follow-up of individual patients with DM or PM. The type 1 IFN-inducible gene transcripts in the blood have potential utility for monitoring disease activity in patients with DM or PM.",
keywords = "dermatomyositis, genomics, polymyositis, type 1 interferon",
author = "Greenberg, {S. A.} and Higgs, {B. W.} and C. Morehouse and Walsh, {R. J.} and {Won Kong}, S. and P. Brohawn and W. Zhu and A. Amato and M. Salajegheh and B. White and Kiener, {P. A.} and B. Jallal and Y. Yao",
year = "2012",
month = "4",
doi = "10.1038/gene.2011.61",
language = "English (US)",
volume = "13",
pages = "207--213",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis

AU - Greenberg, S. A.

AU - Higgs, B. W.

AU - Morehouse, C.

AU - Walsh, R. J.

AU - Won Kong, S.

AU - Brohawn, P.

AU - Zhu, W.

AU - Amato, A.

AU - Salajegheh, M.

AU - White, B.

AU - Kiener, P. A.

AU - Jallal, B.

AU - Yao, Y.

PY - 2012/4

Y1 - 2012/4

N2 - The objective of this study was to evaluate the relationship between blood mRNA, disease activity and treatment effects in a longitudinal study of patients with dermatomyositis (DM) or polymyositis (PM). In all, 24 patients with DM or PM were followed for up to 6 years (mean of 1.9 years) at 2-7 follow-up visits while receiving standard clinical care. Clinical data and blood samples collected at 80 patient visits were used for the analysis of cytokine-induced gene expression for the signaling pathways of type 1 interferon (IFN), tumor necrosis factor-α, IL-1β, granulocyte-monocyte colony-stimulating factor, IL-10 and IL-13. A type 1 IFN signature score, but not other cytokine signature scores in the blood of patients with DM or PM, correlated highly with disease activity, decreased significantly with immunomodulatory therapies and showed concordant changes with major changes in disease activity. Type 1 IFN signature score in the blood correlates with disease activity in longitudinal follow-up of individual patients with DM or PM. The type 1 IFN-inducible gene transcripts in the blood have potential utility for monitoring disease activity in patients with DM or PM.

AB - The objective of this study was to evaluate the relationship between blood mRNA, disease activity and treatment effects in a longitudinal study of patients with dermatomyositis (DM) or polymyositis (PM). In all, 24 patients with DM or PM were followed for up to 6 years (mean of 1.9 years) at 2-7 follow-up visits while receiving standard clinical care. Clinical data and blood samples collected at 80 patient visits were used for the analysis of cytokine-induced gene expression for the signaling pathways of type 1 interferon (IFN), tumor necrosis factor-α, IL-1β, granulocyte-monocyte colony-stimulating factor, IL-10 and IL-13. A type 1 IFN signature score, but not other cytokine signature scores in the blood of patients with DM or PM, correlated highly with disease activity, decreased significantly with immunomodulatory therapies and showed concordant changes with major changes in disease activity. Type 1 IFN signature score in the blood correlates with disease activity in longitudinal follow-up of individual patients with DM or PM. The type 1 IFN-inducible gene transcripts in the blood have potential utility for monitoring disease activity in patients with DM or PM.

KW - dermatomyositis

KW - genomics

KW - polymyositis

KW - type 1 interferon

UR - http://www.scopus.com/inward/record.url?scp=84859885032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859885032&partnerID=8YFLogxK

U2 - 10.1038/gene.2011.61

DO - 10.1038/gene.2011.61

M3 - Article

C2 - 21881594

AN - SCOPUS:84859885032

VL - 13

SP - 207

EP - 213

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 3

ER -